Ling Ouyang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 2
-
- Ovarian cancer diagnosis and treatment 7
- Endometriosis Research and Treatment 4
- Co-authors
- Bo Li (2 shared papers)Peng Chen (5 shared papers)Zixuan Song (10 shared papers)Biao Sui (1 shared paper)Yue Zhang (1 shared paper)Haiou Shen (1 shared paper)Kuiran Liu (4 shared papers)Yizi Wang (7 shared papers)
- Journals
- Frontiers in Oncology (7 papers)Frontiers in Endocrinology (4 papers)Oncotarget (2 papers)Journal of Assisted Reproduction and Genetics (2 papers)Frontiers in Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ling Ouyang
46 papers receiving 775 citations
Ling Ouyang's Hit Papers
Peers
Comparison fields: 5 of 111
- Cancer Research 150
- Obstetrics and Gynecology 68
- Reproductive Medicine 69
- Environmental Engineering 62
- Molecular Biology 258
Countries citing papers authored by Ling Ouyang
This map shows the geographic impact of Ling Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Ouyang more than expected).
Fields of papers citing papers by Ling Ouyang
This network shows the impact of papers produced by Ling Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Ouyang. The network helps show where Ling Ouyang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Ouyang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of estrogen receptors in health and disease Hit paper breakdown → | 2022 | 169 |
| 2 | 2019 | 91 | |
| 3 | 2021 | 50 | |
| 4 | 2019 | 42 | |
| 5 | 2017 | 38 | |
| 6 | 2017 | 35 | |
| 7 | 2020 | 33 | |
| 8 | 2021 | 26 | |
| 9 | 2019 | 25 | |
| 10 | 2020 | 24 | |
| 11 | 2013 | 21 | |
| 12 | 2018 | 18 | |
| 13 | 2016 | 18 | |
| 14 | 2022 | 17 | |
| 15 | 2020 | 16 | |
| 16 | 2017 | 16 | |
| 17 | 2021 | 13 | |
| 18 | 2020 | 13 | |
| 19 | Analysis of conservation effectiveness of wetland protected areas based on remote sensing in West Songnen Plain. | 2015 | 11 |
| 20 | 2023 | 10 |
About Ling Ouyang
Ling Ouyang is a scholar working on Molecular Biology, Reproductive Medicine, Cancer Research, Surgery and Oncology, having authored 56 papers that have together received 786 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (7 papers), Cancer-related molecular mechanisms research (7 papers), Endometrial and Cervical Cancer Treatments (5 papers), Endometriosis Research and Treatment (4 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (3 papers), Ubiquitin and proteasome pathways (2 papers) and Urologic and reproductive health conditions (2 papers). The work is most often cited by research in Cancer Research (150 citations), Obstetrics and Gynecology (68 citations), Reproductive Medicine (69 citations), Environmental Engineering (62 citations) and Molecular Biology (258 citations). Ling Ouyang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Bo Li, Peng Chen, Zixuan Song, Biao Sui, Yue Zhang, Haiou Shen, Kuiran Liu, Yizi Wang, Fang Ren and Yan Li. Their work appears in journals such as Frontiers in Oncology, Frontiers in Endocrinology, Oncotarget, Journal of Assisted Reproduction and Genetics and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.